Loading...

U.S. Supreme Court To Consider Transgender Bathroom Case

By | 2017-05-24T20:11:46+00:00 October 28th, 2016|Uncategorized|

The U.S. Supreme Court is poised to consider a groundbreaking case about the rights of transgender students to use bathrooms corresponding to their sexual identity, NPR has reported. Gavin Grimm, a 17-year-old Virginia high school student, is the plaintiff in the case and came out as transgender as a freshman.  The school principal initially allowed [...]

Comments Off on U.S. Supreme Court To Consider Transgender Bathroom Case

Haeggquist & Eck LLP Announces Investigation of ProNAi Therapeutics, Inc. (DNAI)

By | 2017-05-24T20:12:53+00:00 October 28th, 2016|Uncategorized|

Haeggquist & Eck, LLP, a shareholder and consumer rights litigation firm has commenced an investigation into ProNAi Therapeutics, Inc. (DNAI) (“ProNAi”) relating to potential violations of federal securities laws. ProNAi is a clinical stage oncology company with a focus on pioneering a novel class of therapeutics based on its proprietary DNA interference (“DNAi”) technology platform. [...]

Comments Off on Haeggquist & Eck LLP Announces Investigation of ProNAi Therapeutics, Inc. (DNAI)

Gov. Brown Signs Legislation Expanding Employee Protections in California

By | 2017-05-24T20:12:09+00:00 October 24th, 2016|Uncategorized|

In a sweeping move to expand the protections of California’s Fair Pay Act, Governor Brown has signed legislation that will prohibit employers from race and ethnicity discrimination in the payment of wages. SB 1063 amends the state Fair Pay Act to include race and ethnicity and prohibits an employer from paying any employee at wage [...]

Comments Off on Gov. Brown Signs Legislation Expanding Employee Protections in California

Haeggquist & Eck Sues Interwest Consulting Group for Wrongful Termination In Violation of Family Medical Leave Act and California Family Rights Act

By | 2017-05-24T20:12:24+00:00 October 24th, 2016|Uncategorized|

The employee rights advocates at Haeggquist & Eck have sued Interwest Consulting, Inc. for wrongful termination on behalf of the company’s former Director of Marketing. Plaintiff Sherry Beck is represented by Haeggquist & Eck attorneys Alreen Haeggquist and Aaron Olsen. Her lawsuit alleges that she was fired in September 2015, while on protected leave following the [...]

Comments Off on Haeggquist & Eck Sues Interwest Consulting Group for Wrongful Termination In Violation of Family Medical Leave Act and California Family Rights Act

Haeggquist & Eck Files Age Discrimination Lawsuit Against Largest U.S. Propane Distributor

By | 2017-05-24T20:12:39+00:00 October 24th, 2016|Uncategorized|

AmeriGas Propane, the nation’s largest propane distributor, wrongfully terminated and discriminated against a 67-year-old employee based on his age, a lawsuit recently filed by Haeggquist & Eck alleges. Jay Reeb worked for AmeriGas as a propane delivery driver for more than 26 years without a single negative writeup before he was fired for forgetting to [...]

Comments Off on Haeggquist & Eck Files Age Discrimination Lawsuit Against Largest U.S. Propane Distributor

Haeggquist & Eck Joins Lawyers Club Of San Diego’s #FLOTUStoSD Campaign

By | 2017-05-24T20:13:24+00:00 October 21st, 2016|Uncategorized|

Haeggquist & Eck is proud to join Lawyers Club of San Diego in its bid to persuade First Lady Michelle Obama to travel to America’s Finest City to speak to Lawyers Club members. In connection with the organization’s campaign, Haeggquist & partners Amber Eck and Alreen Haeggquist wrote to the First Lady to ask that [...]

Comments Off on Haeggquist & Eck Joins Lawyers Club Of San Diego’s #FLOTUStoSD Campaign

Haeggquist & Eck Announces Investigation of KemPharm, Inc.

By | 2017-05-24T20:13:47+00:00 September 30th, 2016|Uncategorized|

Haeggquist & Eck, LLP has commenced an investigation into (“KemPharm”) (NASDAQ: KMPH) to determine whether KemPharm and its Officers and Directors have violated the federal securities laws. KemPharm is a clinical-stage specialty pharmaceutical company, discovers and develops new proprietary prodrugs in the United States. KemPharm was founded in 2006 and is headquartered in Coralville, Iowa. On [...]

Comments Off on Haeggquist & Eck Announces Investigation of KemPharm, Inc.

Alreen Haeggquist Recognized Among “40 Under 40” by SD Metro Magazine

By | 2017-05-24T20:14:02+00:00 September 16th, 2016|Uncategorized|

Haeggquist & Eck Managing Partner Alreen Haeggquist was recognized as one of SD Metro Magazine’s “40 Under 40” in a ceremony Friday, September 16. Haeggquist & Eck LLP, Alreen is dedicated to representing employees who have been wrongfully terminated or otherwise harassed and discriminated against at work. Alreen has successfully represented employees in cases involving wrongful termination, retaliation, wage theft, contract violations, sexual harassment, and all types [...]

Comments Off on Alreen Haeggquist Recognized Among “40 Under 40” by SD Metro Magazine

Haeggquist & Eck Partner Amber Eck Named Master in Welsh Inn of Court

By | 2017-05-24T20:14:17+00:00 September 16th, 2016|Uncategorized|

Congratulations to Amber Eck for being named a Master in the Louis M. Welsh American Inn of Court! Founded in San Diego in 1983 by Judges William B. Enright, Howard B. Turrentine, and attorneys William G. Bailey and Robert G. Steiner, the Welsh Inn is the ninth Inn chartered in the United States. The Inn’s [...]

Comments Off on Haeggquist & Eck Partner Amber Eck Named Master in Welsh Inn of Court

Haeggquist & Eck Announces Investigation of INSYS Therapeutics, Inc.

By | 2017-05-24T20:14:29+00:00 June 30th, 2016|Uncategorized|

Haeggquist & Eck, LLP has commenced an investigation into possible violations of the federal securities laws by certain officers and directors at INSYS Therapeutics, Inc. (“Insys” or the “Company”) (NASDAQ: INSY). Insys is a specialty pharmaceutical company that develops and commercializes supportive care products primarily designed to assist patients with pain management. Insys’s core product and [...]

Comments Off on Haeggquist & Eck Announces Investigation of INSYS Therapeutics, Inc.